TORONTO, Sept. 05, 2018 (GLOBE NEWSWIRE) -- Platinex Inc. (CSE:PTX) (“Platinex” or the "Company") announces the appointment of Robert Blake as Co-CEO and Director, subject to standard regulatory approvals.



Following the Company’s press release August 2, 2018, where Robert Blake III was announced as a Director of the Company, the Company Board of Directors is please to announce the appointment of Bob Blake as Co CEO. Walter Henry, President and Co-CEO stated, "We are pleased to add a seasoned businessman with the breadth and depth of business experience that Bob holds across many states in the U.S.A particularly Oregon. We look forward to Bob’s knowledge of the business environment in Oregon, to his input and direction given his impressive hands-on businesses successes as the Company evaluates alternatives to the mining segment”.

Bob Blake has been an advisor to physicians, manager of health care operations, and a health care investor for more than thirty (30) years. In 2013 with the passage of new legislation and after months of research regarding the medicinal benefits off cannabinoids, Bob invested in the Oregon cannabis industry. His investments began with vertically integrated operations of a grow facility, an extraction processor, and a dispensary. His Oregon cannabis holdings now include multiple grow facilities and dispensaries, an extraction processor, and a wholesale operation.

Bob was raised in New York City where he graduated from The Collegiate School. He has a B.A. Economics degree from Brown University and an M.B.A. in finance from The Wharton School of the University of Pennsylvania.

About Platinex Inc.

Platinex is focused on developing various strategies to capitalize on the lucrative growth of the cannabis sector in North America. At the same time, Platinex has been focusing its mining business efforts in assembling a very large property in the Shining Tree gold camp, which has received little modern exploration compared to other gold camps in the Abitibi greenstone Belt. Shares of Platinex are listed for trading on the Canadian Securities Exchange under the symbol "PTX".

For further information, please contact:

Walter Henry, President and CEO

416-414-5825

Email: info@platinex.com

David Posner

647-985-6727

Email: dposner44@gmail.com

To receive Company press releases, please email lparadis@platinex.com and

mention “Platinex press release” on the subject line.

FORWARD-LOOKING STATEMENTS:

This news release may contain forward-looking statements and information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Such statements include submission of the relevant documentation within the required timeframe and to the satisfaction of the relevant regulators, completing the acquisition of the applicable assets and raising sufficient financing to complete the Company's business strategy. There is no certainty that any of these events will occur. Although such statements are based on management's reasonable assumptions, there can be no assurance that such assumptions will prove to be correct. We assume no responsibility to update or revise them to reflect new events or circumstances.

Investing into early stage companies, inherently carries a high degree of risk and investment into securities of the Company shall be considered highly speculative. Furthermore, the Company seeks to enter the cannabis market in the United States, where some states have legalized cannabis for medical or adult recreational use, while cannabis remain illegal under United States Federal law. As such, the Company may become subject to additional government regulation and legal uncertainties that could restrict the demand for its services or increase its cost of doing business, thereby adversely affecting its financial results.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any province in which such offer, solicitation or sale would be unlawful. The securities issued, or to be issued, under the Private Placement have not been, and will not be, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.